Early Lung Disease in Infants and Preschool Children with Cystic Fibrosis What Have We Learned and What Should We Do about It?

被引:97
|
作者
Ranganathan, Sarath C. [1 ,2 ,3 ]
Hall, Graham L. [4 ,5 ,6 ]
Sly, Peter D. [7 ,8 ]
Stick, Stephen M. [4 ,5 ,9 ]
Douglas, Tonia A. [4 ,7 ]
机构
[1] Royal Childrens Hosp, Dept Resp Med, Melbourne, Vic, Australia
[2] Murdoch Childrens Res Inst, Infect & Immun, Melbourne, Vic, Australia
[3] Univ Melbourne, Dept Paediat, Melbourne, Vic, Australia
[4] Telethon Kids Inst, Perth, WA, Australia
[5] Univ Western Australia, Ctr Child Hlth Res, Perth, WA, Australia
[6] Curtin Univ, Sch Physiotherapy & Exercise Sci, Perth, WA, Australia
[7] Childrens Hlth Queensland, Dept Resp & Sleep Med, South Brisbane, Qld, Australia
[8] Univ Queensland, Child Hlth Res Ctr, Brisbane, Qld, Australia
[9] Princess Margaret Hosp Children, Dept Resp Med, Perth, WA, Australia
关键词
cystic fibrosis; early lung disease; newborn screening; early intervention; PSEUDOMONAS-AERUGINOSA ACQUISITION; YOUNG-CHILDREN; COMPUTED-TOMOGRAPHY; PULMONARY INFLAMMATION; AIRWAY INFLAMMATION; CLEARANCE INDEX; DORNASE-ALPHA; VENTILATION INHOMOGENEITY; BRONCHOALVEOLAR LAVAGE; RESPIRATORY-INFECTION;
D O I
10.1164/rccm.201606-1107CI
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The past decade has seen significant advances in understanding of the pathogenesis and progression of lung disease in cystic fibrosis (CF). Pulmonary inflammation, infection, and structural lung damage manifest very early in life and are prevalent among preschool children and infants, often in the absence of symptoms or signs. Early childhood represents a pivotal period amenable to intervention strategies that could delay or prevent the onset of lung damage and alter the longer-term clinical trajectory for individuals with CF. This review summarizes what we have learned about early lung disease in children with CF and discusses the implications for future clinical practice and research.
引用
收藏
页码:1567 / 1575
页数:9
相关论文
共 50 条
  • [1] WHAT WE HAVE LEARNED ABOUT PREVENTION - WHAT WE SHOULD DO ABOUT IT
    DONNELLY, AHC
    CHILD ABUSE & NEGLECT, 1991, 15 : 99 - 106
  • [2] What Have We Learned About Early Treatment of Pseudomonas aeruginosa Infection in Infants and Children With Cystic Fibrosis?
    Saiman, Lisa
    Cohen, Mitchell B.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2011, 165 (09): : 867 - 868
  • [3] CLINICAL EVOLUTION OF INFANTS WITH CYSTIC FIBROSIS: WHAT HAVE WE LEARNED?
    Ishikawa, Caren
    Watanabe, Rai Andre S.
    de Sillos, Marcela Duarte
    Barbisan, Beatriz N.
    Chiba, Sonia Mayumi
    Tadeu Gomes, Clovis Eduardo
    PEDIATRIC PULMONOLOGY, 2016, 51 : S33 - S34
  • [4] What have we learned and what can we do about NPS?
    D'Agnone, Oscar
    DRUGS AND ALCOHOL TODAY, 2015, 15 (01) : 28 - 37
  • [5] WHAT WE SHOULD HAVE LEARNED ABOUT CONTROLS
    GUZZARDI, W
    FORTUNE, 1975, 91 (03) : 102 - &
  • [7] Early lung surveillance of cystic fibrosis: what have we learnt?
    Foong, Rachel E.
    Rosenow, Tim
    Garratt, Luke W.
    Hall, Graham L.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2017, 11 (01) : 1 - 3
  • [8] Audits of postoperative analgesia: what have we learned and what should we do now?
    Howard, Richard F.
    PEDIATRIC ANESTHESIA, 2010, 20 (02) : 117 - 118
  • [9] Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
    Godoy, Luani Rezende
    Possati-Resende, Julio Cesar
    Guimaraes, Yasmin Medeiros
    Pedrao, Priscila Grecca
    dos Reis, Ricardo
    Longatto-Filho, Adhemar
    CANCERS, 2022, 14 (11)
  • [10] Ocular toxoplasmosis Outbreak: what we learned and what we should have learned?
    Fiorot, Clara Amaral Silva Perini Fiorot
    Coblentz, Jacqueline
    da Costa, Deise Fialho
    Gondim, Luis Armando Vitorino Alves de Souza
    Almeida, Milena Cristina da Silva
    Belfort, Rubens, Jr.
    Burnier, Miguel N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)